Standout Papers

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons... 2018 2026 2020 2023 313
  1. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC) (2018)
    Young Kwang Chae, Ayush Arya et al. Journal for ImmunoTherapy of Cancer

Immediate Impact

8 from Science/Nature 57 standout
Sub-graph 1 of 21

Citing Papers

A vision–language foundation model for precision oncology
2025 StandoutNature
Activatable Photosensitizers: From Fundamental Principles to Advanced Designs
2025 Standout
2 intermediate papers

Works of Sunandana Chandra being referenced

A multicenter characterization of hepatitis associated with immune checkpoint inhibitors
2021
Immune Checkpoint Inhibitor Toxicity in 2018
2018

Author Peers

Author Last Decade Papers Cites
Sunandana Chandra 789 413 326 47 1.2k
Riccardo Marconcini 973 445 400 48 1.3k
Lucia Festino 853 361 367 39 1.2k
Barbara Merelli 811 307 359 41 1.0k
Shu‐Fen Chiang 671 708 472 52 1.6k
Jingjing Zhao 575 359 277 70 1.1k
Antonella Romanini 769 433 299 72 1.6k
Spyros Retsas 474 399 158 69 989
Farah Khalil 644 308 441 35 1.2k
Xue Zhang 708 297 292 46 1.0k
Geny Piro 667 786 250 58 1.5k

All Works

Loading papers...

Rankless by CCL
2026